Commentary

Amyloid imaging in clinical trials

Rik Ossenkoppele , Niels D Prins and Bart NM van Berckel

Alzheimer's Research & Therapy 2013, 5:36 (14 August 2013)

Ossenkoppele and colleagues comment on the possibilities of amyloid imaging in clinical trials with disease-modifying agents, methodological considerations for reliable longitudinal amyloid imaging and alternative quantitative approaches.

Subscription required

All research articles in Alzheimer's Research & Therapy are open access. The journal also publishes a range of other articles that are available to subscribers.

Existing subscribers

Forgotten your password? help